• Home
  • NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models.

NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models.

Author List
Li H, Peyser ND, Zeng Y, Ha PK, Johnson DE, Grandis JR
Publication
Cancers
Publication ID (Profile URL)
https://researcherprofiles.org/profile/269269625
Publication Year
2022
PubMed ID
35158773
Publication Title
Li H, Peyser ND, Zeng Y, Ha PK, Johnson DE, Grandis JR. NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models. Cancers (Basel). 2022 Jan 20; 14(3).